Supplementary Tables – Efficacy and Safety of First-Line Therapies in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Network Meta-Analysis

Table
A1. Full search strategy for Embase.

<b>Table A2. Full search
strategy for MEDLINE.</b>
<b>Table A3. Full search
strategy for Cochrane.</b>
<b>Table A4. Trials identified
from the SLR (n=57).</b>
<b>Table A5. PFS evidence for overall
EGFRm+ NSCLC patient population, by mutation type, and by geographical region.</b>
<b>Table A6. OS evidence for
overall EGFRm+ NSCLC patient population.</b>
<b>Table A7. Base case PFS
- pairwise comparisons of all interventions and comparators.</b>
<b> </b>
<b>Table A8. Base case OS -
pairwise comparisons of all interventions and comparators.</b>